Associations between the human growth hormone-releasing hormone- and neuropeptide-Y-immunoreactive systems in the human diencephalon: A possible morphological substrate of the impact of stress on growth

[1]  R. Kineman,et al.  Severity of the catabolic condition differentially modulates hypothalamic expression of growth hormone-releasing hormone in the fasted mouse: potential role of neuropeptide Y and corticotropin-releasing hormone. , 2008, Endocrinology.

[2]  Koichi Kitamura,et al.  Direct evidence that stimulation of neuropeptide Y Y5 receptor activates hypothalamo-pituitary-adrenal axis in conscious rats via both corticotropin-releasing factor- and arginine vasopressin-dependent pathway. , 2007, Endocrinology.

[3]  B. Dudas,et al.  Three‐Dimensional Representation of the Neurotransmitter Systems of the Human Hypothalamus: Inputs of the Gonadotrophin Hormone‐Releasing Hormone Neuronal System , 2006, Journal of neuroendocrinology.

[4]  C. Barb,et al.  Neuropeptide Y modulates growth hormone but not luteinizing hormone secretion from prepuberal gilt anterior pituitary cells in culture. , 2005, Domestic animal endocrinology.

[5]  R. Kineman,et al.  Fasting-induced changes in the hypothalamic-pituitary-GH axis in the absence of GH expression: lessons from the spontaneous dwarf rat. , 2004, The Journal of endocrinology.

[6]  D. Swaab,et al.  Hypothalamic growth hormone‐releasing hormone (GHRH) cell number is increased in human illness, but is not reduced in Prader–Willi syndrome or obesity , 2003, Clinical endocrinology.

[7]  L. D. van de Kar,et al.  Neuroendocrine pharmacology of stress. , 2003, European journal of pharmacology.

[8]  G. Berghe.  Dynamic neuroendocrine responses to critical illness , 2002, Frontiers in Neuroendocrinology.

[9]  G. Thomas,et al.  Hypothalamic Y2 receptors regulate bone formation. , 2002, The Journal of clinical investigation.

[10]  B. Dudas,et al.  Topography and associations of luteinizing hormone–releasing hormone and neuropeptide Y–immunoreactive neuronal systems in the human diencephalon , 2000, The Journal of comparative neurology.

[11]  G. V. Berghe,et al.  Novel insights into the neuroendocrinology of critical illness , 2000 .

[12]  C. Hammond,et al.  Hypothalamic and Hypophyseal Regulation of Growth Hormone Secretion , 1998, Cellular and Molecular Neurobiology.

[13]  J. Volaufova,et al.  Effect of restraint stress on food intake and body weight is determined by time of day. , 1997, American journal of physiology. Regulatory, integrative and comparative physiology.

[14]  P. Thorén,et al.  Neuropeptide Y Y1 Receptor Antagonist (BIBP 3226) Attenuates Stress Evoked Tachycardia in Conscious Spontaneously Hypertensive Rats , 1997, Cardiovascular Drugs and Therapy.

[15]  R. Peter,et al.  Growth hormone-releasing hormone immunoreactivity in the brain, pituitary, and pineal of the goldfish, Carassius auratus. , 1996, General and comparative endocrinology.

[16]  K.,et al.  Regulation of hypothalamic neuropeptide-Y neurons by growth hormone in the rat. , 1996, Endocrinology.

[17]  E. Karwatowska-Prokopczuk,et al.  Stress-induced mesenteric vasoconstriction in rats is mediated by neuropeptide Y Y1 receptors. , 1996, The American journal of physiology.

[18]  Z. Żukowska-Grójec.  Neuropeptide Y , 1995, Annals of the New York Academy of Sciences.

[19]  R. Stanhope,et al.  Failure to grow: lack of food or lack of love? , 1994, Professional care of mother and child.

[20]  D. Matthews,et al.  Reversibility of physiological growth hormone secretion in children with psychosocial dwarfism , 1994 .

[21]  M. Ono,et al.  Characterization and Localization of Mouse Hypothalamic Growth Hormone‐Releasing Factor and Effect of Gold Thioglucose‐Induced Hypothalamic Lesions , 1994, Journal of neuroendocrinology.

[22]  A. Armario,et al.  Effects of chronic immobilization stress on GH and TSH secretion in the rat: Response to hypothalamic regulatory factors , 1993, Psychoneuroendocrinology.

[23]  G. Chrousos,et al.  The endocrinology of stress and stress system disorders in adolescence. , 1993, Endocrinology and metabolism clinics of North America.

[24]  L. Puybasset,et al.  Effects of Clonidine on Plasma Catecholamines and Neuropeptide Y in Hypertensive Patients at Rest and During Stress , 1993, Journal of cardiovascular pharmacology.

[25]  M. Tancer,et al.  Evidence for hypothalamo-growth hormone dysfunction in panic disorder: profile of growth hormone (GH) responses to clonidine, yohimbine, caffeine, glucose, GRF and TRH in panic disorder patients versus healthy volunteers. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.

[26]  Z. Żukowska-Grójec,et al.  Cardiovascular, neuropeptide Y, and adrenergic responses in stress are sexually differentiated , 1991, Physiology & Behavior.

[27]  S. Nielsen,et al.  Reversible Somatotropin Deficiency (Psychosocial Dwarfism) Presenting as Conduct Disorder and Growth Hormone Deficiency , 1990, Developmental medicine and child neurology.

[28]  B. Bloch,et al.  Comparative immunohistochemical study of the distribution of neuropeptide Y, growth hormone-releasing factor and the carboxyterminus of precursor protein GHRF in the human hypothalamic infundibular area. , 1990, Neuroendocrinology.

[29]  F. Gallyas,et al.  Copper-H2O2 oxidation strikingly improves silver intensification of the nickel-diaminobenzidine (Ni-DAB) end-product of the peroxidase reaction. , 1988, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[30]  P. Ciofi,et al.  Colocalization of GHRF and NPY immunoreactivities in neurons of the infundibular area of the human brain. , 1988, Neuroendocrinology.

[31]  M. Preece,et al.  PHYSIOLOGICAL GROWTH HORMONE (GH) SECRETION DURING THE RECOVERY FROM PSYCHOSOCIAL DWARFISM: A CASE REPORT , 1988, Clinical endocrinology.

[32]  C. Diéguez,et al.  GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES , 1988 .

[33]  A. Sollevi,et al.  Release of neuropeptide Y upon haemorrhagic hypovolaemia in relation to vasoconstrictor effects in the pig. , 1987, Acta physiologica Scandinavica.

[34]  V. Castagné,et al.  Stress-induced changes of circulating neuropeptide Y in the rat: comparison with catecholamines , 1987, Regulatory Peptides.

[35]  J. Chalmers,et al.  Plasma Neuropeptide Y Concentration Is Increased After Hemorrhage in Conscious Rats: Relative Contributions of Sympathetic Nerves and the Adrenal Medulla , 1987, Journal of cardiovascular pharmacology.

[36]  M. Venetikou,et al.  Neuropeptide Y directly inhibits growth hormone secretion by human pituitary somatotropic tumours. , 1987, Acta endocrinologica.

[37]  P. Ciofi,et al.  Coexistence of hGHRF and NPY immunoreactivities in neurons of the arcuate nucleus of the rat. , 1987, Neuroendocrinology.

[38]  L. Swanson,et al.  Colocalization of neuropeptide Y immunoreactivity in brainstem catecholaminergic neurons that project to the paraventricular nucleus of the hypothalamus , 1985, The Journal of comparative neurology.

[39]  L. Swanson,et al.  The distribution of growth‐hormone‐releasing factor (GRF) immunoreactivity in the central nervous system of the rat: An immunohistochemical study using antisera directed against rat hypothalamic GRF , 1985, The Journal of comparative neurology.

[40]  J. Powell,et al.  An arcuato-paraventricular and -dorsomedial hypothalamic neuropeptide Y-containing system which lacks noradrenaline in the rat , 1985, Brain Research.

[41]  A. Arimura,et al.  Immunocytochemical localization of growth hormone releasing factor (GHRF)-containing structures in the rat brain using anti-rat GHRF serum , 1984, Peptides.

[42]  A. Schally,et al.  Immunocytochemical localization of growth hormone-releasing factor in the rat hypothalamus. , 1984, Endocrinology.

[43]  J. Willoughby,et al.  Growth hormone releasing factor immunoreactivity in rat hypothalamus , 1984, Neuropeptides.

[44]  N. Ling,et al.  Topographical and ontogenetic study of the neurons producing growth hormone-releasing factor in human hypothalamus , 1984, Regulatory Peptides.

[45]  F. Bloom,et al.  Topographical study of the neurons containing hpGRF immunoreactivity in monkey hypothalamus , 1983, Neuroscience Letters.

[46]  D. Jacobowitz,et al.  Localization of GRF-like immunoreactive neurons in the rat brain , 1983, Peptides.

[47]  F. Bloom,et al.  Immunohistochemical detection of growth hormone-releasing factor in brain , 1983, Nature.

[48]  F. Gallyas,et al.  High-grade intensification of the end-product of the diaminobenzidine reaction for peroxidase histochemistry. , 1982, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[49]  W. Vale,et al.  Effects of lesions in the periventricular nucleus of the preoptic-anterior hypothalamus on growth hormone and thyrotropin secretion and brain somatostatin , 1981, Brain Research.

[50]  G. Granditsch,et al.  [Psychosomal dwarfism with reversible growth hormone deficiency (author's transl)]. , 1979, Wiener klinische Wochenschrift.

[51]  R. Rice,et al.  Abolition of plasma growth hormone response to stress and of the circadian rhythm in pituitary-adrenal function in female rats with preoptic-anterior hypothalamic lesions , 1978, Brain Research.

[52]  J. Money.  The syndrome of abuse dwarfism (psychosocial dwarfism or reversible hyposomatotropism). , 1977, American journal of diseases of children.

[53]  G. Paxinos,et al.  THE HUMAN NERVOUS SYSTEM , 1975 .

[54]  A. Drash,et al.  Psychosocial Dwarfism: Environmentally Induced Recovery , 1969, Psychosomatic medicine.

[55]  R. Blizzard,et al.  Emotional deprivation and growth retardation simulating idiopathic hypopituitarism. II. Endocrinologic evaluation of the syndrome. , 1967, The New England journal of medicine.

[56]  R. Blizzard,et al.  Emotional deprivation and growth retardation simulating true idiopathic hypopituitarism , 1966 .

[57]  L. Al-Ayadhi.  Neurohormonal changes in medical students during academic stress , 2005, Annals of Saudi medicine.

[58]  H. Braak,et al.  The hypothalamus of the human adult: chiasmatic region , 2004, Anatomy and Embryology.

[59]  G. Van den Berghe,et al.  Critical illness as a model of hypothalamic ageing. , 2002, Novartis Foundation symposium.

[60]  I. Meredith,et al.  Region-specific neuropeptide Y overflows at rest and during sympathetic activation in humans. , 1997, Hypertension.

[61]  R. Steiner,et al.  Role of NPY neurones in GH-dependent feedback signalling to the brain. , 1996, Hormone research.

[62]  G. Chrousos,et al.  Neuroendocrinology of stress: implications for growth and development. , 1995, Hormone research.

[63]  M. de Kerdanet,et al.  [Growth retardation of psychosocial origin. Clinical and biological aspects in four cases]. , 1993, Pediatrie.

[64]  Z. Żukowska-Grójec,et al.  Role of neuropeptide Y (NPY) in cardiovascular responses to stress , 1988, Synapse.

[65]  M. Konarska,et al.  Differential plasma catecholamine and neuropeptide Y responses to acute stress in rats. , 1988, Life sciences.

[66]  W. H. Green,et al.  Psychosocial dwarfism: a critical review of the evidence. , 1984, Journal of the American Academy of Child Psychiatry.

[67]  M. New,et al.  Somatomedin and growth hormone in psychosocial dwarfism. , 1977, Padiatrie und Padologie. Supplementum.

[68]  R. Lechan,et al.  Printed in U.S.A. Copyright © 1998 by The Endocrine Society The Arcuate Nucleus Is the Major Source for Neuropeptide Y-Innervation of Thyrotropin-Releasing Hormone Neurons in the Hypothalamic Paraventricular Nucleus* , 2022 .